Allergies News and Research

Latest Allergies News and Research

Discontinuing oral antibiotics after breast reconstruction does not lead to an increase in infections

For breast cancer patients undergoing breast reconstruction after mastectomy, avoiding postoperative oral antibiotics does not reduce the risk of infections, reports a study in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

27 Apr 2023

Colchicine therapy benefits pediatric long COVID patients suffering from recurring fever

Researchers at National Jewish Health found that a subset of children suffering recurring fevers as a result of long COVID-19, benefited from a daily medication treatment commonly used for gout and periodic fever syndrome.

25 Apr 2023

Does maternal peanut consumption protect against infant peanut allergies?

Researched determined whether maternal consumption of peanuts while breastfeeding protects the infant from allergies.

25 Apr 2023

New class of immunotherapy shows promise against aggressive skin cancer

A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.

25 Apr 2023

RSV infection in the first year of life associated with increased risk of childhood asthma

Severe respiratory syncytial virus (RSV) infection has long been associated with the onset of childhood wheezing diseases, but the relationship between RSV infection during infancy and the development of childhood asthma has remained unclear.

24 Apr 2023

Most kids recover from Lyme disease within six months of completing antibiotic treatment

A majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment, according to a new joint study from Children's National Research Institute and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, published in Pediatric Research.

21 Apr 2023

Greenness around the home does not protect children from atopic eczema

According to a new Finnish study, greenness around the home in early childhood does not seem to protect children from atopic eczema.

21 Apr 2023

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

20 Apr 2023

GW one of 18 clinical trial sites across the United States testing monkeypox vaccine in adolescents

The National Institutes of Health trial to evaluate the mpox (previously known as monkeypox) vaccine JYNNEOS has now entered the next stage and is studying the immune responses to and the safety of the vaccine in adolescents.

19 Apr 2023

The importance and challenges of developing mucosal SARS-COV-2 vaccines

In November 2022, the National Institute of Allergy and Infectious Diseases co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2.

13 Apr 2023

The confusing fate of the abortion pill

The abortion pill mifepristone is now ground zero in the abortion debate.

13 Apr 2023

How to combat and lessen seasonal allergy symptoms

Welcoming spring this year has been bittersweet for the millions of allergy sufferers already experiencing itchy eyes, nasal congestion, sneezing and runny noses.

13 Apr 2023

Cornell receives $9.5 million NIH grant for chronic fatigue research

A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Disease – funding that will enable experts from disparate fields to work together on the mysterious and debilitating condition.

11 Apr 2023

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

11 Apr 2023

Mint flavor in vaping liquids associated with worse lung function in e-cigarette users

Adding mint flavor to e-cigarette liquids produces more vapor particles and is associated with worse lung function in those who smoke, report researchers from the University of Pittsburgh in Respiratory Research today.

11 Apr 2023

Regulatory T cell populations descend from two different origins, finds study

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children's Hospital of Philadelphia (CHOP).

7 Apr 2023

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.

6 Apr 2023

Children with asthma more likely to develop anxiety

Children diagnosed with asthma were at significantly increased risk of developing anxiety, a University of Queensland study has found.

5 Apr 2023

Mosquitoes' saliva contains immune-dampening substances to increase infectivity of dengue viruses

The saliva of mosquitoes infected with dengue viruses contains a substance that thwarts the human immune system and makes it easier for people to become infected with these potentially deadly viruses, new research reveals.

4 Apr 2023

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.

4 Apr 2023

Allergies News and Research

Latest Allergies News and Research

Discontinuing oral antibiotics after breast reconstruction does not lead to an increase in infections

Colchicine therapy benefits pediatric long COVID patients suffering from recurring fever

Does maternal peanut consumption protect against infant peanut allergies?

New class of immunotherapy shows promise against aggressive skin cancer

RSV infection in the first year of life associated with increased risk of childhood asthma

Most kids recover from Lyme disease within six months of completing antibiotic treatment

Greenness around the home does not protect children from atopic eczema

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

GW one of 18 clinical trial sites across the United States testing monkeypox vaccine in adolescents

The importance and challenges of developing mucosal SARS-COV-2 vaccines

The confusing fate of the abortion pill

How to combat and lessen seasonal allergy symptoms

Cornell receives $9.5 million NIH grant for chronic fatigue research

Daily statin medication could improve cardiovascular outcomes in people with HIV

Mint flavor in vaping liquids associated with worse lung function in e-cigarette users

Regulatory T cell populations descend from two different origins, finds study

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

Children with asthma more likely to develop anxiety

Mosquitoes' saliva contains immune-dampening substances to increase infectivity of dengue viruses

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Allergies News and Research

Latest Allergies News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in